Phio Pharmaceuticals Corp
About
Phio Pharmaceuticals Corp (NASDAQ:PHIO) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 13 2026
Phio Pharmaceuticals Announces "Nobel Prize Winning Science Takes on Skin Cancer" in a Fireside Chat with Force Family Office on Wednesday, April 15, 2026
Apr 9 2026
Phio Pharmaceuticals Announces Presentation at Centri Capital Conference on April 14, 2026
Mar 30 2026
Phio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762
Mar 23 2026
Phio Pharmaceuticals Announces American Academy of Dermatology 2026 Presentation Featuring Clinical Study Results from Study of PH-762 for Cutaneous Carcinoma Underscoring Clinical Pipeline Advancement
Mar 16 2026
Phio Pharmaceuticals Announces "A Groundbreaking Approach to Treating Skin Cancer" in a Fireside Chat with Force Family Office
Financials
Revenue
$0
Market Cap
$14.64 M
EPS
-1.45